These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28960722)

  • 1. Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
    Fussey JM; Khan H; Ahsan F; Prashant R; Pettit L
    Head Neck; 2017 Dec; 39(12):2567-2572. PubMed ID: 28960722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy.
    Baran J; Isaza A; Bojarsky M; Alzoebie L; Song M; Halada S; Sisko L; Gonzales S; Mostoufi-Moab S; Bauer AJ
    Front Endocrinol (Lausanne); 2024; 15():1443394. PubMed ID: 39205688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer.
    Freudenthal B; Williams GR
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):325-328. PubMed ID: 28043744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Francia G; Davì MV; Petroziello A; Sussi PL
    Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
    Jin S; Yang YT; Bao W; Bai Y; Ai JW; Liu Y; Yong H
    Endocrine; 2019 Aug; 65(2):327-337. PubMed ID: 31056722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH suppression by octreotide in differentiated thyroid carcinoma.
    Maini CL; Sciuto R; Tofani A
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):335-9. PubMed ID: 8187297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
    Altuntaş SÇ; Hocaoğlu Ç
    Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
    Santoro AB; Vargens DD; Barros Filho Mde C; Bulzico DA; Kowalski LP; Meirelles RM; Paula DP; Neves RR; Pessoa CN; Struchine CJ; Suarez-Kurtz G
    Br J Clin Pharmacol; 2014 Nov; 78(5):1067-75. PubMed ID: 24910925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease.
    Bunevicius R; Jakuboniene N; Jurkevicius R; Cernicat J; Lasas L; Prange AJ
    Endocrine; 2002 Jul; 18(2):129-33. PubMed ID: 12374459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
    Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.
    Olveira G; Almaraz MC; Soriguer F; Garriga MJ; Gonzalez-Romero S; Tinahones F; Ruiz de Adana MS
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):707-11. PubMed ID: 9274701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
    Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of hypothyroidism therapy with thyroid hormone].
    Fang L; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):396-9. PubMed ID: 15884564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.